Meena Bedi, MD, MS

Publications

• FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.

  (Karmakar D, Lahiri P, Bedi M, Ghosh A, Ghosh A, Barui A, Varshney SK, Lahiri B, Sengupta S.) J Cell Biochem. 2023 Jun;124(6):849-860 PMID: 37158093 05/09/2023

• Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.

  (Wang D, Harris J, Kraybill WG, Eisenberg B, Kirsch DG, Ettinger DS, Kane JM 3rd, Barry PN, Naghavi A, Freeman CR, Chen YL, Hitchcock YJ, Bedi M, Salerno KE, Severin D, Godette KD, Larrier NA, Curran WJ Jr, Torres-Saavedra PA, Lucas DR.) JAMA Oncol. 2023 May 01;9(5):646-655 PMID: 36995690 PMCID: PMC10064284 03/31/2023

• Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.

  (Gutkin PM, Gore E, Charlson J, Neilson JC, Johnstone C, King DM, Hackbarth DA, Wooldridge A, Mannem R, Bedi M.) Radiat Oncol. 2023 Mar 01;18(1):42 PMID: 36859309 PMCID: PMC9976442 SCOPUS ID: 2-s2.0-85149210071 03/02/2023

• Outcomes of plastic surgical reconstruction in extremity and truncal soft tissue sarcoma: Results from the US Sarcoma Collaborative.

  (Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal H.) J Surg Oncol. 2023 Mar;127(4):550-559 PMID: 36477427 SCOPUS ID: 2-s2.0-85147711222 12/09/2022

• Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.

  (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA.) Adv Radiat Oncol. 2023;8(4):101206 PMID: 37152489 PMCID: PMC10157111 05/08/2023

• Extraskeletal myxoid chondrosarcoma: Clinicopathological features and outcomes from the United States sarcoma collaborative database.

  (Gusho CA, King D, Ethun CG, Cardona K, Harrison Howard J, Tran TB, Poultsides G, Tseng J, Roggin KK, Fields RC, Cullinan DR, Chouliaras K, Votanopoulos K, Grignol VP, Bedi M.) J Surg Oncol. 2022 Dec;126(8):1533-1542 PMID: 35962783 SCOPUS ID: 2-s2.0-85135798396 08/14/2022

• Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.

  (Squires MH, Ethun CG, Donahue EE, Benbow JH, Anderson CJ, Jagosky MH, Manandhar M, Patt JC, Kneisl JS, Salo JC, Hill JS, Ahrens W, Prabhu RS, Livingston MB, Gower NL, Needham M, Trufan SJ, Fields RC, Krasnick BA, Bedi M, Votanopoulos K, Chouliaras K, Grignol V, Roggin KK, Tseng J, Poultsides G, Tran TB, Cardona K, Howard JH.) Ann Surg Oncol. 2022 May;29(5):3291-3301 PMID: 35015183 01/12/2022

• Long term clinical outcomes and associated predictors of progression free survival in anal canal cancer.

  (Ponce SEB, Erickson BA, Hall WA, Bedi M, Martens MJ, Siker M, Thomas J, George B, Ludwig K, Peterson C, Ridolfi T, Longo JM.) J Gastrointest Oncol. 2022 Feb;13(1):185-196 PMID: 35284138 PMCID: PMC8899735 03/15/2022

• Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma.

  (Bedi M, Singh R, Charlson JA, Kelly T, Johnstone C, Wooldridge A, Hackbarth DA, Moore N, Neilson JC, King DM.) Adv Radiat Oncol. 2022;7(3):100850 PMID: 35647402 PMCID: PMC9133395 06/02/2022

• Dosimetric predictors of local control and complications in gynecologic transperineal implant patients: The medical college of wisconsin experience.

  (Zeitlin R, Yu G, Wheatley M, Morrow N, Rownd J, Rein L, Banerjee A, Bedi M, Erickson B.) Brachytherapy. 2022;21(1):94-109 PMID: 34937684 SCOPUS ID: 2-s2.0-85121459405 12/24/2021

• Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas.

  (Ellison C, King DM, Neilson JC, Wooldridge A, Charlson JA, Hackbarth DA, Johnstone C, Bedi M.) Am J Clin Oncol. 2021 Dec 01;44(12):619-623 PMID: 34753886 SCOPUS ID: 2-s2.0-85120362291 11/11/2021

• Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity.

  (Olson CR, Suarez-Kelly LP, Ethun CG, Shelby RD, Yu PY, Hughes TM, Palettas M, Tran TB, Poultsides G, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, King DM, Bedi M, Pollock RE, Grignol VP, Cardona K, Howard JH.) Am Surg. 2021 Nov;87(11):1752-1759 PMID: 34758653 SCOPUS ID: 2-s2.0-85119115004 11/12/2021